Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 318

1.
2.

Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.

Sáiz PA, García-Portilla MP, Arango C, Morales B, Arias B, Corcoran P, Fernández JM, Alvarez V, Coto E, Bascarán MT, Bousoño M, Fañanas L, Bobes J.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):26-31. doi: 10.1016/j.pnpbp.2009.09.008. Epub 2009 Sep 17.

PMID:
19766158
3.

Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene.

Rybakowski JK, Borkowska A, Czerski PM, Hauser J.

Psychiatry Res. 2002 Dec 15;113(1-2):49-57.

PMID:
12467945
4.

Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.

Segman RH, Heresco-Levy U, Finkel B, Inbar R, Neeman T, Schlafman M, Dorevitch A, Yakir A, Lerner A, Goltser T, Shelevoy A, Lerer B.

Psychopharmacology (Berl). 2000 Nov;152(4):408-13.

PMID:
11140333
5.

Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case-control study and meta-analysis.

Utsunomiya K, Shinkai T, De Luca V, Hwang R, Sakata S, Fukunaka Y, Chen HI, Ohmori O, Nakamura J.

Neurosci Lett. 2008 Oct 24;444(2):161-5. doi: 10.1016/j.neulet.2008.08.005. Epub 2008 Aug 7.

PMID:
18703116
6.

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients.

Steen VM, Løvlie R, MacEwan T, McCreadie RG.

Mol Psychiatry. 1997 Mar;2(2):139-45.

PMID:
9106238
7.

[Study of association between the ser-9-gly polymorphism of the D3 dopaminergic receptor and schizophrenia].

Cordeiro Q Jr, Junqueira R, Vallada H.

Arq Neuropsiquiatr. 2001 Jun;59(2-A):219-22. Portuguese.

8.
9.

Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia.

Chen CH, Liu MY, Wei FC, Koong FJ, Hwu HG, Hsiao KJ.

Am J Med Genet. 1997 Feb 21;74(1):40-3.

PMID:
9034004
10.

Association study between schizophrenia and dopamine D3 receptor gene polymorphism.

Tanaka T, Igarashi S, Onodera O, Tanaka H, Takahashi M, Maeda M, Kameda K, Tsuji S, Ihda S.

Am J Med Genet. 1996 Jul 26;67(4):366-8.

PMID:
8837704
12.

Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis.

Jönsson EG, Flyckt L, Burgert E, Crocq MA, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, Nimgaonkar VL, Edman G, Bjerkenstedt L, Wiesel FA, Sedvall GC.

Psychiatr Genet. 2003 Mar;13(1):1-12.

PMID:
12605094
13.

Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia.

Segman R, Neeman T, Heresco-Levy U, Finkel B, Karagichev L, Schlafman M, Dorevitch A, Yakir A, Lerner A, Shelevoy A, Lerer B.

Mol Psychiatry. 1999 May;4(3):247-53.

PMID:
10395214
14.

Are eye movement abnormalities indicators of genetic vulnerability to schizophrenia?

Boudet C, Bocca ML, Chabot B, Delamillieure P, Brazo P, Denise P, Dollfus S.

Eur Psychiatry. 2005 Jun;20(4):339-45.

PMID:
16018927
15.

Association between schizophrenia and DRD3 or HTR2 receptor gene variants.

Baritaki S, Rizos E, Zafiropoulos A, Soufla G, Katsafouros K, Gourvas V, Spandidos DA.

Eur J Hum Genet. 2004 Jul;12(7):535-41.

16.

Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.

Woo SI, Kim JW, Rha E, Han SH, Hahn KH, Park CS, Sohn JW.

Psychiatry Clin Neurosci. 2002 Aug;56(4):469-74.

17.

Examination of new and reported data of the DRD3/MscI polymorphism: no support for the proposed association with schizophrenia.

Hawi Z, McCabe U, Straub RE, O'Neill A, Kendler KS, Walsh D, Gill M.

Mol Psychiatry. 1998 Mar;3(2):150-5.

PMID:
9577839
18.

Homozygosity at the dopamine D3 receptor gene in schizophrenic patients.

Durany N, Thome J, Palomo A, Foley P, Riederer P, Cruz-Sánchez FF.

Neurosci Lett. 1996 Dec 20;220(3):151-4.

PMID:
8994215
19.

Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome.

Mihara K, Kondo T, Suzuki A, Yasui-Furukori N, Ono S, Sano A, Koshiro K, Otani K, Kaneko S.

Am J Med Genet B Neuropsychiatr Genet. 2003 Feb;117B(1):57-60.

PMID:
12555236
20.

COMT val(158)met genotype and smooth pursuit eye movements in schizophrenia.

Haraldsson HM, Ettinger U, Magnusdottir BB, Sigmundsson T, Sigurdsson E, Ingason A, Petursson H.

Psychiatry Res. 2009 Sep 30;169(2):173-5. doi: 10.1016/j.psychres.2008.10.003. Epub 2009 Jul 31.

PMID:
19647329

Supplemental Content

Support Center